Comparison of efficacy of masitinib versus placebo in the treatment of Crohn's disease Porovnanie účinnosťi a bezpečnosťi masitinibu oproti placebu, pri liečbe miernej Crohnovej choroby

Update Il y a 4 ans
Reference: EUCTR2012-004222-25

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Enhanced clinical response, defined as a decrease in CDAI (Crohn’s Disease Activity Index) ≥ 100 at W12 Zvýšená klinická odpoveď, definovaná ako pokles CDAI (Index Crohnova choroba činnosti) ≥ 100 na W12


Inclusion criteria

  • Crohn’s Disease,Crohnova choroba